Human Genome Sciences

  HGSI 31.50 +0.26 (+0.8%)

Human Genome Sciences Incorporated is a biopharmaceutical company that runs clinical trials relating to Hepatitis C, lupus, inhalation anthrax and cancer. A main focus has been the commercialization of Albuferon in order to treat such diseases.

What do YOU think?

Use the icons below to select how you think HGSI will perform over the next 90 days. Just like you'd suspect, red is bad and green is good.

    Sentiment
  • Spc

    Sentiment

  • Very High

    Activity

Have something to say?

Register for Piqqem
and give us your take on Human Genome Sciences

  • sun

    Last month

    Load it for long goal